The General Office of the Xi'an Municipal People's Government issued the “Implementation Plan to Promote Capacity Enhancement in the Biomedical Industry”, which proposes a chemical and biopharmaceutical industry chain group. Expand the scale of the chemical and biopharmaceutical industry through “imitation, innovation and transformation”. Consolidate the foundation of the chemical generic drug industry, support enterprises to accelerate the development of chemical generic drugs in the fields of anesthesia, antibiotics, cardiovascular and cerebrovascular, etc., achieve “imitation integration”, and enrich the variety of chemical generic drug products. Driven by achieving a breakthrough of zero innovative drugs, we support enterprises to develop innovative drugs such as liver-targeted drugs, peptide drugs, and stem cell exosomal drugs. Give full play to the resource advantages of universities and medical institutions, increase clinical research cooperation between pharmaceutical companies and medical institutions, and promote the implementation and transformation of new drugs as soon as possible. By 2027, the city will add 16 generic drug products, complete the IND application process for 2-3 new cellular drugs, and strive to reach 12 billion yuan in the scale of the chemical biopharmaceutical chain industry.

The General Office of the Xi'an Municipal People's Government issued the “Implementation Plan to Promote Capacity Enhancement in the Biomedical Industry”, which proposes a chemical and biopharmaceutical industry chain group. Expand the scale of the chemical and biopharmaceutical industry through “imitation, innovation and transformation”. Consolidate the foundation of the chemical generic drug industry, support enterprises to accelerate the development of chemical generic drugs in the fields of anesthesia, antibiotics, cardiovascular and cerebrovascular, etc., achieve “imitation integration”, and enrich the variety of chemical generic drug products. Driven by achieving a breakthrough of zero innovative drugs, we support enterprises to develop innovative drugs such as liver-targeted drugs, peptide drugs, and stem cell exosomal drugs. Give full play to the resource advantages of universities and medical institutions, increase clinical research cooperation between pharmaceutical companies and medical institutions, and promote the implementation and transformation of new drugs as soon as possible. By 2027, the city will add 16 generic drug products, complete the IND application process for 2-3 new cellular drugs, and strive to reach 12 billion yuan in the scale of the chemical biopharmaceutical chain industry.